New: Instantly spot drawdowns, dips, insider moves, and breakout themes across Maps and Screener.

Learn More

GE HealthCare (GEHC) Q4 Earnings Report Preview: What To Look For

By Anthony Lee | February 02, 2026, 10:11 PM

GEHC Cover Image

Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) will be announcing earnings results this Wednesday before market hours. Here’s what investors should know.

GE HealthCare beat analysts’ revenue expectations by 1.5% last quarter, reporting revenues of $5.14 billion, up 5.8% year on year. It was a strong quarter for the company, with a narrow beat of analysts’ organic revenue estimates and a narrow beat of analysts’ revenue estimates.

Is GE HealthCare a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, analysts are expecting GE HealthCare’s revenue to grow 5.3% year on year to $5.60 billion, improving from the 2.2% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.40 per share.

GE HealthCare Total Revenue

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. GE HealthCare has missed Wall Street’s revenue estimates four times over the last two years.

Looking at GE HealthCare’s peers in the healthcare equipment and supplies segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Hologic delivered year-on-year revenue growth of 2.5%, missing analysts’ expectations by 2.1%, and Neogen reported a revenue decline of 2.8%, topping estimates by 7.2%. Hologic’s stock price was unchanged after the resultswhile Neogen was up 30.4%.

Read our full analysis of Hologic’s results here and Neogen’s results here.

Investors in the healthcare equipment and supplies segment have had steady hands going into earnings, with share prices flat over the last month. GE HealthCare is down 5.9% during the same time and is heading into earnings with an average analyst price target of $92.15 (compared to the current share price of $80.05).

Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.

Latest News